Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure

Completed

Conditions studied: Atrial Fibrillation, Heart Failure

In brief

Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation and Heart Failure who are beginning oral blood thinners

Key facts

Study ID

NCT03508271

Run by

Bristol-Myers Squibb

People needed

60000

Starts

2017-11-30

Expected to finish

2018-11-08

Last updated by the study team

2019-01-04

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Were age greater than or equal to 65 years as of the index date
• Had greater than or equal to 1 diagnosis of AF prior to or on the index date
• Had greater than or equal to 1 diagnosis claim of HF during the 12 months prior to or on the index date
• Had 1 or more pharmacy claim for oral blood thinners

You may not qualify if…

• Claims indicating diagnosis or procedure for hip/knee replacement surgery within 6 weeks prior to index date
• Pharmacy claim for warfarin, apixaban, dabigatran, edoxaban or rivaroxaban during the 12-month baseline period
• Greater than 1 oral anticoagulants prescription claim on the index date and/or with a follow-up less than 1 day
• Had medical claim indicating VTE in the 12 months prior to index date
• Other protocol defined inclusion/exclusion criteria could apply

Where it is running

• Local Institution — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.